Oxygène Médicinal Gazeux Vivisol (Oxygen)

Oxygène Médicinal Gazeux Vivisol is a medical gas used in respiratory support and related clinical pathways.

• Acute hypoxemia: provides supplemental oxygen to raise arterial oxygen levels.
• Peri‑operative care: maintains adequate oxygenation during anesthesia and surgery.
• Emergency medicine: delivers high‑flow oxygen for trauma, cardiac arrest and other urgent situations.
• Chronic respiratory disease management: assists patients with COPD or interstitial lung disease during exacerbations.
• Neonatal care: supports preterm infants with under‑developed lungs.
• Hyperbaric therapy adjunct: used as the carrier gas in hyperbaric oxygen chambers.

• Oxygen diffuses across alveolar membranes into the pulmonary capillary blood, increasing the partial pressure of oxygen in arterial blood. This enhances cellular respiration by providing the substrate required for oxidative phosphorylation, thereby improving tissue oxygen delivery and supporting metabolic processes in hypoxic conditions.

Oxygen therapy is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nasal dryness or irritation: discomfort in the nasal passages from high‑flow delivery.
• Headache: mild to moderate headache related to changes in carbon dioxide levels.
• Cough: irritation of the airway causing a cough reflex.
• Fatigue: transient tiredness after prolonged exposure.
• Burning sensation: feeling of warmth at the cannula or mask site.

Serious or Rare Side Effects

• Pulmonary oxygen toxicity: lung injury from prolonged high concentrations.
• Fire hazard: increased risk of combustion when oxygen is present near flammable sources.
• Hypercapnia: elevated carbon dioxide levels in patients with hypoventilation.
• Visual disturbances: temporary changes in vision due to retinal oxygen overload.
• Barotrauma: ear or sinus injury from rapid pressure changes during high‑flow administration.

When using Oxygène Médicinal Gazeux Vivisol, follow established clinical guidelines and monitor patients closely.

• Assess patient need: confirm indication and target oxygen saturation before initiating therapy.
• Adjust flow rate: titrate to the lowest flow that maintains adequate oxygenation.
• Monitor for toxicity: watch for signs of pulmonary oxygen toxicity during prolonged high‑concentration use.
• Avoid fire sources: keep away from open flames, sparks and combustible materials.
• Special populations: use caution in patients with chronic CO2 retention, such as severe COPD.
• Store at ambient temperature: keep cylinders in a well‑ventilated, dry area away from direct sunlight and heat sources.

Oxygen can influence the efficacy and safety of several concurrent therapies. Proper assessment and monitoring are essential.

Major Interactions (Avoid)

• Flammable anesthetics: increased fire risk when oxygen is combined with volatile agents.
• Nitric oxide therapy: high oxygen concentrations can reduce the vasodilatory effect of inhaled nitric oxide.

Moderate Interactions (Monitor Closely)

• Sedatives and opioids: enhanced respiratory depression risk; monitor ventilation.
• Chemotherapy agents (e.g., bleomycin): oxygen may exacerbate pulmonary toxicity.
• Antioxidant supplements: theoretical reduction in therapeutic benefit of hyperbaric oxygen.
• Inhaled bronchodilators: may require dose adjustment due to improved oxygenation.
• High‑flow nasal cannula systems: ensure compatibility of equipment and flow settings.